Literature DB >> 10623773

Evaluation of VP22 spread in tissue culture.

N Brewis1, A Phelan, J Webb, J Drew, G Elliott, P O'Hare.   

Abstract

We compare methods of detection of intercellular transport of the herpes simplex virus protein VP22 and of a green fluorescent protein (GFP)-VP22 fusion protein. Spread of both proteins was observed by immunofluorescence (IF) using organic fixatives. Spread of both proteins was also detected by IF after paraformaldehyde (PFA) fixation and detergent permeabilization, albeit at reduced levels. However, while spread of GFP-VP22 was observed by examining intrinsic GFP fluorescence after methanol fixation, little spread was observed after PFA fixation, suggesting that the levels of the fusion protein in recipient cells were below the detection limits of intrinsic-fluorescence or that PFA fixation quenches the fluorescence of GFP-VP22. We further considered whether elution of VP22 from methanol-fixed cells and postfixation binding to surrounding cells contributed to the increased detection of spread observed after methanol fixation. The results show that while this could occur, it appeared to be a minor effect not accounting for the observed VP22 cell-to-cell spread in culture.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623773      PMCID: PMC111631          DOI: 10.1128/jvi.74.2.1051-1056.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  Quantification of VP22-GFP spread by direct fluorescence in 15 commonly used cell lines.

Authors:  W A Wybranietz; F Prinz; M Spiegel; A Schenk; M Bitzer; M Gregor; U M Lauer
Journal:  J Gene Med       Date:  1999 Jul-Aug       Impact factor: 4.565

2.  Intercellular spread of GFP-VP22.

Authors:  A Aints; M S Dilber; C I Smith
Journal:  J Gene Med       Date:  1999 Jul-Aug       Impact factor: 4.565

3.  The herpes simplex virus type 1 tegument protein VP22 is encoded by gene UL49.

Authors:  G D Elliott; D M Meredith
Journal:  J Gen Virol       Date:  1992-03       Impact factor: 3.891

Review 4.  The green fluorescent protein.

Authors:  R Y Tsien
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

5.  Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells.

Authors:  B Fang; B Xu; P Koch; J A Roth
Journal:  Gene Ther       Date:  1998-10       Impact factor: 5.250

6.  Intercellular trafficking and protein delivery by a herpesvirus structural protein.

Authors:  G Elliott; P O'Hare
Journal:  Cell       Date:  1997-01-24       Impact factor: 41.582

7.  Phosphorylation of the herpes simplex virus type 1 tegument protein VP22.

Authors:  G Elliott; D O'Reilly; P O'Hare
Journal:  Virology       Date:  1996-12-01       Impact factor: 3.616

8.  GFP in mammalian cells.

Authors:  J Pines
Journal:  Trends Genet       Date:  1995-08       Impact factor: 11.639

9.  An amino acid sequence shared by the herpes simplex virus 1 alpha regulatory proteins 0, 4, 22, and 27 predicts the nucleotidylylation of the UL21, UL31, UL47, and UL49 gene products.

Authors:  J A Blaho; C Mitchell; B Roizman
Journal:  J Biol Chem       Date:  1994-07-01       Impact factor: 5.157

10.  Herpes simplex virus type 1 tegument protein VP22 induces the stabilization and hyperacetylation of microtubules.

Authors:  G Elliott; P O'Hare
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

View more
  22 in total

1.  The many ways to cross the plasma membrane.

Authors:  D J Stephens; R Pepperkok
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  The role of the cytoskeleton in the life cycle of viruses and intracellular bacteria: tracks, motors, and polymerization machines.

Authors:  E L Bearer; P Satpute-Krishnan
Journal:  Curr Drug Targets Infect Disord       Date:  2002-09

3.  Induction of insolubility by herpes simplex virus VP22 precludes intercellular trafficking of N-terminal Apoptin-VP22 fusion proteins.

Authors:  Saskia A Rutjes; Piter J Bosma; Jennifer L Rohn; Mathieu H M Noteborn; John G Wesseling
Journal:  J Mol Med (Berl)       Date:  2003-07-16       Impact factor: 4.599

4.  Cellular internalization of human calcitonin derived peptides in MDCK monolayers: a comparative study with Tat(47-57) and penetratin(43-58).

Authors:  Rachel Tréhin; Ulrike Krauss; Roman Muff; Martina Meinecke; Annette G Beck-Sickinger; Hans P Merkle
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

5.  Replication-competent herpes simplex virus 1 isolates selected from cells transfected with a bacterial artificial chromosome DNA lacking only the UL49 gene vary with respect to the defect in the UL41 gene encoding host shutoff RNase.

Authors:  Maria Teresa Sciortino; Brunella Taddeo; Maria Giuffrè-Cuculletto; Maria Antonietta Medici; Antonio Mastino; Bernard Roizman
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

6.  The pseudorabies virus VP22 homologue (UL49) is dispensable for virus growth in vitro and has no effect on virulence and neuronal spread in rodents.

Authors:  T del Rio; H C Werner; L W Enquist
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  Measurement of FRET efficiency and ratio of donor to acceptor concentration in living cells.

Authors:  Huanmian Chen; Henry L Puhl; Srinagesh V Koushik; Steven S Vogel; Stephen R Ikeda
Journal:  Biophys J       Date:  2006-06-30       Impact factor: 4.033

8.  Bovine herpesvirus 1 VP22 enhances the efficacy of a DNA vaccine in cattle.

Authors:  Chunfu Zheng; Lorne A Babiuk; Sylvia van Drunen Littel-van den Hurk
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

9.  Bovine herpesvirus 1 tegument protein VP22 interacts with histones, and the carboxyl terminus of VP22 is required for nuclear localization.

Authors:  X Ren; J S Harms; G A Splitter
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

10.  The varicella-zoster virus (VZV) ORF9 protein interacts with the IE62 major VZV transactivator.

Authors:  Cristian Cilloniz; Wallen Jackson; Charles Grose; Donna Czechowski; John Hay; William T Ruyechan
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.